NIH-funded research NIH-funded research

Understanding how a chromatin regulator keeps gene expression correct

Official title: Mechanism of Kumgang/Mi-2 complex for transcriptional fidelity

Funded at Cornell University · NIH-11420761 · Data updated 2026-11-12

This project looks at how specific proteins keep genes turned on or off correctly to prevent cancer-related misexpression.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCornell University
NIH-funded
Lab location1 site (Ithaca, United States)
Project startJuly 21, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$424,158
NIH project number1R35GM165297-01
Project IDNIH-11420761 on NIH RePORTER

Who could benefit from this research

Could help

No specific patient participation is described in the grant; the work is basic science in cellular and genomic contexts.

Less likely to help

Direct patient benefits are not part of the current plan, as it focuses on fundamental mechanisms in model systems.

What this research studies

Scientists will study how chromatin is bundled in cells to stop inappropriate transcription, focusing on how Kumgang and Mi-2 complexes control gene repression. The research will map where these regulators attach in the genome and how they change the patterns of gene activity during development and in cancer. By using model systems and human-relevant contexts, the team aims to reveal core principles of transcriptional control that could inform new therapeutic strategies. The work is designed to build a clearer picture of why some genes go rogue and how cells maintain their identity. Over five years, findings could point to targets for correcting faulty gene expression in diseases.

Why it matters

Potential benefit: Better understanding of transcriptional repression could lead to new approaches to prevent or treat cancers driven by misregulated genes.

How similar studies have gone: Previous studies have shown that chromatin regulators like Mi-2 complex influence gene expression patterns in development and cancer, supporting the potential value of this line of work.

Where this research is happening

  • Cornell University
    Ithaca, United States
    Active

Researchers

  • Principal investigator: Kim, Jongmin — Cornell University
  • Study coordinator: Kim, Jongmin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.